135 related articles for article (PubMed ID: 6722932)
21. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
Ferrara R; Tolando R; King LJ; Manno M
Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458
[TBL] [Abstract][Full Text] [Related]
22. Factors affecting the formation of chlorotrifluoroethane and chlorodifluoroethylene from halothane.
Maiorino RM; Sipes IG; Gandolfi AJ; Brown BR; Lind RC
Anesthesiology; 1981 May; 54(5):383-9. PubMed ID: 7224207
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect of gomisi on reductive metabolism of halothane.
Jiaxiang N; Fujii K; Sato N; Yuge O
J Appl Toxicol; 1993; 13(6):385-8. PubMed ID: 8288841
[TBL] [Abstract][Full Text] [Related]
24. Aerobic dehalogenation of halothane showing different substrate dependency from anaerobic dehalogenation in liver microsomes of guinea pig.
Nakao M; Fujii K; Kinoshita H; Yuge O; Morio M
Hiroshima J Med Sci; 1991 Mar; 40(1):23-8. PubMed ID: 1864763
[TBL] [Abstract][Full Text] [Related]
25. Reductive metabolism of halothane in children.
Plummer JL; Van der Walt JH; Cousins MJ
Anaesth Intensive Care; 1984 Nov; 12(4):293-5. PubMed ID: 6517287
[TBL] [Abstract][Full Text] [Related]
26. The mechanism of the suicidal reductive inactivation of microsomal cytochrome P-450 by halothane.
Manno M; Cazzaro S; Rezzadore M
Arch Toxicol; 1991; 65(3):191-8. PubMed ID: 2053846
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of corticoids on reductive halothane dehalogenation.
Fujii K
Drug Metabol Drug Interact; 1995; 12(1):37-43. PubMed ID: 7555000
[TBL] [Abstract][Full Text] [Related]
28. Time-course of formation of volatile reductive metabolites of halothane in humans and an animal model.
Gourlay GK; Adams JF; Cousins MJ; Sharp JH
Br J Anaesth; 1980 Mar; 52(3):331-6. PubMed ID: 7370149
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of volatile halothane metabolites in biological tissues by gas chromatography.
Maiorino RM; Sipes IG; Gandolfi AJ; Brown BR
J Chromatogr; 1979 Sep; 164(1):63-72. PubMed ID: 541398
[TBL] [Abstract][Full Text] [Related]
30. Genetic differences in reductive metabolism and hepatotoxicity of halothane in three rat strains.
Gourlay GK; Adams JF; Cousins MJ; Hall P
Anesthesiology; 1981 Aug; 55(2):96-103. PubMed ID: 7258721
[TBL] [Abstract][Full Text] [Related]
31. Anaerobic release of fluoride from halothane. Relationship to the binding of halothane metabolites to hepatic cellular constituents.
Van Dyke RA; Gandolf AJ
Drug Metab Dispos; 1976; 4(1):40-4. PubMed ID: 3400
[TBL] [Abstract][Full Text] [Related]
32. Effects of piperonyl butoxide on halothane hepatotoxicity and metabolism in the hyperthyroid rat.
Smith AC; Roberts SM; Berman LM; Harbison RD; James RC
Toxicology; 1988 Jun; 50(1):95-105. PubMed ID: 3388433
[TBL] [Abstract][Full Text] [Related]
33. Isoflurane and cytochrome b5 stimulation of 2-chloro-1,1-difluoroethene metabolism by reconstituted rat CYP2B1 and CYP2C6.
Ronnenberg WC; Wang Y; Baker MT
Biochem Pharmacol; 1995 Aug; 50(4):521-8. PubMed ID: 7646559
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the NADPH-dependent covalent binding of [14C]halothane to human liver microsomes: a role for cytochrome P4502E1 at low substrate concentrations.
Madan A; Parkinson A
Drug Metab Dispos; 1996 Dec; 24(12):1307-13. PubMed ID: 8971135
[TBL] [Abstract][Full Text] [Related]
35. A comparative study on the irreversible binding of labeled halothane trichlorofluoromethane, chloroform, and carbon tetrachloride to hepatic protein and lipids in vitro and in vivo.
Uehleke H; Werner T
Arch Toxicol; 1975 Dec; 34(4):289-308. PubMed ID: 3152
[TBL] [Abstract][Full Text] [Related]
36. Reductive activation of HCFC-123 by methaemalbumin.
Zanovello A; Ferrara R; Manno M
Toxicol Lett; 2003 Sep; 144(1):127-36. PubMed ID: 12919730
[TBL] [Abstract][Full Text] [Related]
37. The in vitro metabolism of halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) by hepatic microsomal cytochrome P-450.
Karashima D; Hirokata Y; Shigematsu A; Furukawa T
J Pharmacol Exp Ther; 1977 Nov; 203(2):409-16. PubMed ID: 909072
[TBL] [Abstract][Full Text] [Related]
38. Comparison of covalent binding from halothane metabolism in hepatic microsomes from phenobarbital-induced and hyperthyroid rats.
Smith AC; Roberts SM; James RC; Berman LM; Harbison RD
Xenobiotica; 1988 Aug; 18(8):991-1001. PubMed ID: 3188577
[TBL] [Abstract][Full Text] [Related]
39. Isoflurane-chlorodifluoroethene interaction in human liver microsomes. Role of cytochrome P4502B6 in potentiation of haloethene metabolism.
Baker MT; Olson MJ; Wang Y; Ronnenberg WC; Johnson JT; Brady AN
Drug Metab Dispos; 1995 Jan; 23(1):60-4. PubMed ID: 7720526
[TBL] [Abstract][Full Text] [Related]
40. Exposure to the chlorofluorocarbon substitute 2,2-dichloro-1,1,1- trifluoroethane and the anesthetic agent halothane is associated with transient protein adduct formation in the heart.
Huwyler J; Gut J
Biochem Biophys Res Commun; 1992 May; 184(3):1344-9. PubMed ID: 1590796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
